Corporate Advisory

PharmaDeals v2

PharmaTelevision

Industry Insight and Intelligence

Shopping Cart

Your shopping cart contains 1 items

 

PTV Latest

Cancer Research Technology: Keith Blundy on Collaborating with Big Pharma

More
Image of woman with pen

Register for E-Mail Updates

Email Address
Submit

Keeping You Updated

Here is a selection of recent PharmaVentures press releases...

< 1 2 3 4 5 6 7 8 >

As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals® Resource Expands its Deal Coverage

Oxford, UK, August 19 2010: PharmaVentures, the company behind the PharmaDeals®; range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

More...

Biopharma Companies Gain Financially Through Unique Targeted Access to the Financial Community

OXFORD, UK, June 7, 2010 /PRNewswire: PharmaTelevision® today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector.

More...

PharmaTelevision Partners with Reuters Insider to Deliver BioPharma Insight to the Global Financial Community

Oxford, UK, May 11, 2010: PharmaTelevision® announced that as of today the groundbreaking online TV channel for the BioPharma industry, is teaming up with Reuters Insider, a new interactive on-demand video platform designed to change the way financial professionals consume and distribute news, research and information.

More...

Matrix Corporate Capital and PharmaVentures announce the signing of a Memorandum of Understanding (MOU)

London and Oxford, United Kingdom – March 15, 2010: Matrix Corporate Capital ('Matrix') and PharmaVentures Limited ('PharmaVentures') today announced the signing of a Memorandum of Understanding ('MOU') covering strategic transactions in the biotech, pharmaceutical and med tech sectors. The companies will work together to identify licensing, buyout, investment, IPO and consolidation opportunities which bring together both strategic expertise and capital from Europe's dedicated healthcare investors.

More...

< 1 2 3 4 5 6 7 8 >